Managing Conflicts and Maximizing Transparency in Industry-Funded Research

, , &
AJOB Empirical Bioethics 11 (4):223-232 (2020)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Add categories

Keywords

Reprint years

DOI

10.1080/23294515.2020.1798562

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,122

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Addressing Industry-Funded Research with Criteria for Objectivity.Kevin C. Elliott - 2018 - Philosophy of Science 85 (5):857-868.
Health Professionals “Make Their Choice”: Pharmaceutical Industry Leaders’ Understandings of Conflict of Interest.Quinn Grundy, Lisa Tierney, Christopher Mayes & Wendy Lipworth - 2017 - Journal of Bioethical Inquiry 14 (4):541-553.
Democratizing Strategies for Industry-Funded Medical Research: A Cautionary Tale.Manuela Fernández Pinto - 2018 - Philosophy of Science 85 (5):882-894.
Industry relationships of dod-funded academics and institutional changes in the us university system.Dirk Libaers - unknown
Maximizing research progress through Open Access mandates and metrics.Stevan Harnad - unknown
Taking conflicts of interest seriously without overdoing it: Promises and perils of academic-industry partnerships. [REVIEW]Jason Borenstein & Yvette E. Pearson - 2008 - Journal of Academic Ethics 6 (3):229-243.
Transparency Trade-Offs: Priority Setting, Scarcity, and Health Fairness.Govind Persad - 2019 - In I. Glenn Cohen, Barbara Evans, Holly Lynch & Carmel Shachar (eds.), Transparency in Health and Health Care. New York: Cambridge UP.
Managing financial conflicts of interest in clinical research.Jordan J. Cohen - 2002 - Science and Engineering Ethics 8 (3):401-406.
Donor-funded research: permissible, not perfect.Mike King & Angela Ballantyne - 2019 - Journal of Medical Ethics 45 (1):36-40.
Financial interests and research bias.David B. Resnik - 2000 - Perspectives on Science 8 (3):255-285.
When patient advocacy organizations meet industry: a novel approach to dealing with financial conflicts of interest.Orna Ehrlich, Laura Wingate, Caren Heller & Inmaculada de Melo-Martin - 2019 - BMC Medical Ethics 20 (1):1-8.
Sex Drugs and Corporate Ventriloquism: How to Evaluate Science Policies Intended to Manage Industry-Funded Bias.Bennett Holman & Sally Geislar - 2018 - Philosophy of Science 85 (5):869-881.
Attitudes of academic and clinical researchers toward financial ties in research: A systematic review.Bonnie E. Glaser & Lisa A. Bero - 2005 - Science and Engineering Ethics 11 (4):553-573.
Conflict of interest disclosure in biomedical research: a review of current practices, biases, and the role of public registries in improving transparency. [REVIEW]Florence T. Bourgeois, Kenneth D. Mandl, Enrico Coiera & Adam G. Dunn - 2016 - Research Integrity and Peer Review 1 (1).
Conflict of interest and its significance in science and medicine warsaw, Poland, 5–6 April, 2002.Wendy Baldwin - 2002 - Science and Engineering Ethics 8 (3):469-475.

Analytics

Added to PP
2020-08-19

Downloads
9 (#1,154,504)

6 months
4 (#573,918)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

Add more citations

References found in this work

Null. Null - 2016 - Philosophy Study 6 (9).
“Institutional Corruption” Defined.Lawrence Lessig - 2013 - Journal of Law, Medicine and Ethics 41 (3):553-555.

Add more references